First U.K Implants Made for Omega Platinum Chromium Coronary Stent
March 24, 2011 - The first implant in the United Kingdom of the Omega Platinum Chromium Bare-Metal Coronary Stent System was announced by Boston Scientific. The stent recently received CE mark approval. The first implant was performed by Dr. Neal Uren, consultant cardiologist, Royal Infirmary of Edinburgh.
The stent incorporates a unique platinum chromium (PtCr) alloy designed specifically for coronary stenting and is intended to provide interventional cardiologists a bare-metal stent with improved acute performance in treating patients with coronary artery disease.
"Omega is a highly deliverable stent, with fantastic conformability to the natural shape of the vessel. The Platinum Chromium alloy also provides excellent strength and radiopacity. In my opinion, these qualities highlight Omega as a definite step-up in the Bare Metal stent market" Uren said.
The Omega is part of the Boston Scientifc’s PtCr stent series, which includes the Taxus Element Paclitaxel-Eluting Stent and Promus Element Everolimus-Eluting Stent Systems. All three stents feature the novel PtCr alloy and an innovative stent design, which combine to offer greater radial strength and flexibility while reducing stent recoil. The higher density alloy provides superior visibility while permitting thinner struts compared to prior-generation stents. The enhanced delivery system features a dual-layer balloon and is engineered to improve access to challenging lesions.
The Omega is offered in 48 different sizes ranging in diameter from 2.25 mm to 4.5 mm and lengths of 8 mm to 32 mm.
For more information: www.bostonscientific.com
More like this
- Third-Generation Bare-Metal Coronary Stent Launched in Europe
- Boston Scientific Begins Omega Stent Trial Enrollment
- HORIZONS II AMI Trial Examines Promus Element Verses Omega Stent
- FDA Clears Promus Element Plus Coronary Stent System
- Boston Scientific Completes Enrollment in Pivotal Trial for New Everolimus Stent